Alfuzosin is prescribed to manage lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). A common inquiry concerns the onset of its therapeutic effects. Patients typically seek to understand the expected timeframe for symptom relief after initiating treatment.
Understanding the time course for efficacy is significant because it allows patients to manage expectations and adhere to their prescribed regimen. Gradual improvement can be observed within days of starting the medication, although the full benefit may take several weeks to manifest. This knowledge is essential for patient compliance and preventing premature discontinuation due to perceived ineffectiveness.